Professional Seasonal Analysis for Trading

Amylyx Pharmaceuticals, Inc. - Common Stock (AMLX)

Seasonality Analysis

Stocks 5 Years Analyzed

Amylyx Pharmaceuticals, Inc. - Common Stock Annual Seasonality Statistics

81.64%
Avg Annual Return
54.2%
Avg Monthly Win Rate
8/12
Positive Months
5
Years Analyzed

Amylyx Pharmaceuticals, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January 12.51%
80%
Very Strong
February 8.46%
60%
Moderate
March WORST -28.88%
20%
Very Weak
April 1.37%
40%
Weak
May -6.66%
25%
Very Weak
June BEST 37.73%
75%
Very Strong
July 21.32%
100%
Very Strong
August 4.71%
50%
Weak
September 22.42%
75%
Very Strong
October 21.47%
50%
Weak
November -0.46%
50%
Weak
December -12.36%
25%
Very Weak

Amylyx Pharmaceuticals, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
93.35
Historical Avg Position
20.03
Deviation
+73.32
Performance
Significantly Above Average

Amylyx Pharmaceuticals, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for AMLX with overlay patterns, custom date ranges, and more.

Create Free Account

Amylyx Pharmaceuticals, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Amylyx Pharmaceuticals, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for AMLX across multiple timeframes.

Create Free Account

About Amylyx Pharmaceuticals, Inc. - Common Stock (AMLX) Seasonality

Amylyx Pharmaceuticals, Inc. - Common Stock (AMLX) has been analyzed using 5 years of historical data to identify seasonal patterns. Classified under Stocks, Amylyx Pharmaceuticals, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Amylyx Pharmaceuticals, Inc. - Common Stock is historically June, with an average return of 37.73% and a win rate of 75%. Conversely, March tends to be the weakest month, averaging -28.88% return.

Looking at the full calendar year, Amylyx Pharmaceuticals, Inc. - Common Stock has an average annual return of 81.64% with an overall monthly win rate of 54.2%. Out of 12 months, 8 typically show positive average returns.

The seasonal pattern for Amylyx Pharmaceuticals, Inc. - Common Stock has a consistency score of 27.5 (Poor), based on 5 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Amylyx Pharmaceuticals, Inc. - Common Stock Seasonality FAQ

What is the best month to buy Amylyx Pharmaceuticals, Inc. - Common Stock (AMLX)?

Historically, June has been the best month for Amylyx Pharmaceuticals, Inc. - Common Stock, with an average return of 37.73% and a win rate of 75%. However, past performance does not guarantee future results.

What is the worst month for Amylyx Pharmaceuticals, Inc. - Common Stock (AMLX)?

Based on historical data, March has been the weakest month for Amylyx Pharmaceuticals, Inc. - Common Stock, with an average return of -28.88%. This is a historical observation and does not guarantee future results.

How reliable is AMLX seasonality data?

The seasonality analysis for Amylyx Pharmaceuticals, Inc. - Common Stock is based on 5 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Amylyx Pharmaceuticals, Inc. - Common Stock seasonality in my trading?

Use Amylyx Pharmaceuticals, Inc. - Common Stock (AMLX) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.